Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1α promoter system

Stem Cells and Development

Volumn 17, Issue 4, 2008, Pages 825-836

  Kwok Keung Chan, Ken ^a,b   Meiyun Wu, Selena ^a   Morin Nissom, Peter ^b   Oh, Steve K W ^a   Choo, Andre B H ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHINESE HAMSTER ELONGATION FACTOR 1ALPHA; ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GERM LAYER; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; KARYOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERATOMA; TISSUE REGENERATION; TISSUE TRANSPLANTATION; TRABECULAR MESHWORK; TRANSGENE;

CRICETULUS GRISEUS; HUMAN HERPESVIRUS 5;

EID: 51849111124     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0233     Document Type: Article

References (38)

1. Menendez P, L Wang and M Bhatia. (2005). Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications. Curr Gene Ther 5:375-385.
2. Kobayashi N, JD Rivas-Carrillo, A Soto-Gutierrez, T Fukazawa, Y Chen, N Navarro-Alvarez and N Tanaka. (2005). Gene delivery to embryonic stem cells. Birth Defects Research Part C 75:10-18.
3. Yates F and GQ Daley. (2006). Progress and prospects: gene transfer into embryonic stem cells. Gene Ther 13:1431-1439.
4. Liew CG, JS Draper, J Walsh, H Moore and PW Andrews. (2007). Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25:1521-1528.
5. Eiges R, M Schuldiner, M Drukker, O Yanuka, J Itskovitz-Eldor and N Benvenisty. (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11:514-518.
6. Lakshmipathy U, B Pelacho, K Sudo, JL Linehan, E Coucouvanis, DS Kaufman and CM Verfaillie. (2004). Efficient transfection of embryonic and adult stem cells. Stem Cells 22:531-543.
7. Vallier L, PJ Rugg-Gunn, IA Bouhon, FK Andersson, AJ Sadler and RA Pedersen. (2004). Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22:2-11.
8. Kim JH, HJ Do, SJ Choi, HJ Cho, KH Park, HM Yang, SH Lee, DK Kim, K Kwack, SK Oh, SY Moon, KY Cha and HM Chung. (2005). Efficient gene delivery in differentiated human embryonic stem cells. Exp Mol Med 37:36-44.
9. Gerrard L, D Zhao, AJ Clark and W Cui. (2005). Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23:124-133.
10. Costa M, M Dottori, E Ng, SM Hawes, K Sourris, P Jamshidi, MF Pera, AG Elefanty and EG Stanley. (2005). The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods 2:259-260.
11. Ma J, A Ramezani, R Lewis, RG Hawley and JA Thomson. (2003). High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21:111-117.
12. Gropp M, P Itsykson, O Singer, T Ben-Hur, E Reinhartz, E Galun and BE Reubinoff. (2003). Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7:281-287.
13. Suter DM, L Cartier, E Bettol, D Tirefort, MA Jaconi, M Dubois-Dauphin and KH Krause. (2006). Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem Cells 24:615-623.
14. Kim S, GJ Kim, H Miyoshi, SH Moon, SE Ahn, JH Lee, HJ Lee, KY Cha and HM Chung. (2007). Efficiency of the elongation factor-1α promoter in mammalian embryonic stem cells using lentiviral gene delivery systems. Stem Cells Dev 16:537-545.
15. Keating A, W Horsfall, RG Hawley and F Toneguzzo. (1990). Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp Hematol 18:99-102.
16. Niwa H, K Yamamura and J Miyazaki. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
17. Najjar SM and RE Lewis. (1999). Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230:41-45.
18. Makrides SC. (1999). Components of vectors for gene transfer and expression in mammalian cells. Protein Express Purif 17:183-202.
19. Liu JW, G Pernod, S Dunoyer-Geindre, RJ Fish, H Yang, H Bounameaux and EK Kruithof. (2006). Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 24: 199-208.
20. Chung S, T Andersson, KC Sonntag, L Bjorklund, O Isacson and KS Kim. (2002). Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells 20:139-145.
21. Running Deer J and DS Allison. (2004). High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene. Biotechnol Prog 20:880-889.
22. Wahl AF, K Klussman, JD Thompson, JH Chen, LV Francisco, G Risdon, DF Chace, CB Siegall and JA Francisco. (2002). The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease. Cancer Res 62:3736-3742.
23. Choo A, J Padmanabhan, A Chin, WJ Fong and SK Oh. (2006). Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions. J Biotechnol. 122:130-141.
24. Chan KK, CKY Wong, VCH Lui, PKH Tam and MH Sham. (2003). Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: differential effects on target gene regulation. J Cell Biochem 90:573-585.
25. Ochman H, AS Gerber and DL Hartl. (1988). Genetic applications of an inverse polymerase chain reaction. Genetics 120:621-623.
26. Ochman H, MM Medhora, D Garza and DL Hartl. (1990). Amplification of flanking sequences by inverse PCR. In: PCR Protocols: A Guide to Methods and Applications. MA Innes, DH Gelfand, JJ Sninsky and TJ White, eds. Academic Press Inc, San Diego, pp. 222-227.
27. Ingham DJ, S Beer, S Money and G Hansen. (2001). Quantitative real-time PCR assay for determining transgene copy number in transformed plants. Biotechniques 31:132-134,136-140.
28. Ballester M, A Castelló, E Ibáñez, A Sáchez and JM Folch. (2004). Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. Biotechniques 37:610-613.
29. Itsykson P, N Ilouz, T Turetsky, R S Goldstein, MF Pera, I Fishbein, M Segal and BE Reubinoff. (2005). Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Mol Cell Neurosci 30:24-36.
30. Gerrard L, L Rodgers and W Cui. (2005). Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 23:1234-1241.
31. Lorenz P, U Harnack and R Morgenstern. (2004). Efficient gene transfer into murine embryonic stem cells by nucleofection. Biotechnol Lett 26:1589-1592.
32. Siemen H, M Nix, E Endl, P Koch, J Itskovitz-Eldor and O Brütle. (2005). Nucleofection of human embryonic stem cells. Stem Cells Dev 14:378-383.
33. Aluigi M, M Fogli, A Curti, A Isidori, E Gruppioni, C Chiodoni, MP Colombo, P Versura, A D'Errico-Grigioni, E Ferri, M Baccarani and RM Lemoli. (2006). Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 24:454-461.
34. Aslan H, Y Zilberman, V Arbeli, D Sheyn, Y Matan, M Liebergall, JZ Li, GA Helm, D Gazit and Z Gazit. (2006). Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 12:877-889.
35. Huang WY, J Aramburu, PS Douglas and S Izumo. (2000). Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6:482-483.
36. Pesce M, M Marin Gomez, S Philipsen and HR Scholer. (1999). Binding of Sp1 and Sp3 transcription factors to the Oct-4 gene promoter. Cell Mol Biol (Noisy-le-grand) 45:709-716.
37. Wu DY and Z Yao. (2006). Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. Cell Res 16:319-322.
38. Moore JC, LW van Laake, SR Braam, T Xue, SY Tsang, D Ward, R Passier, LL Tertoolen, RA Li and CL Mummery. (2005). Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol 20:377-91.